Scotiabank raised the firm’s price target on Johnson & Johnson to $265 from $230 and keeps an Outperform rating on the shares following Q4 results.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson price target raised to $250 from $222 at TD Cowen
- Johnson & Johnson Stock Trending Among Wall Street Analysts
- Johnson & Johnson price target raised to $200 from $197 at Morgan Stanley
- Johnson & Johnson price target raised to $220 from $205 at Stifel
- Johnson & Johnson price target raised to $250 from $240 at Goldman Sachs